Dermoscopy

Patient Buzz: Melanoma Overdiagnosis | The Expert Weighs In
Melanoma OverdiagnosisVerywell Health and several other media outlets are covering the issue of melanoma overdiagnosis in light of a recent study, which estimated more than 80,000 melanomas were overdiagnosed in white Americans in 2018 alone. Is melanoma overdiagnosis among white Americans a significant issue? What are the driving factors of overdiagnosis? What can dermatologists do better when diagnosing melanoma? …
Melanoma Overdiagnosis
Navigating the Complexities of Alopecia: Insights from Dr. Adam Friedman
alopeciasDr. Adam Friedman's lecture at 2024 ODAC conference provided invaluable insights into the nuanced approach required when dealing with patients presenting with alopecia. Addressing the diverse array of alopecia types and their myriad presentations, Dr. Friedman emphasized the significance of a comprehensive clinical history and evaluation to formulate an effective treatment plan. By employing a cas …
alopecias
5 Key Features of Melanoma Under Dermoscopy
dermoscopyNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Jennifer Stein, professor of dermatology at the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine. Watch as Dr. Stein shares five indicators of melanoma that you should look for when using dermoscopy. Find out what differential diagnoses to run through if yo …
dermoscopy
Full Body Skin Exams Practical Pearls
full body skin examThis article provides practical pearls for performing full body skin exams as shared by a panel of dermatology nurse practitioners (NPs) and physician assistants (PAs) during the 2022 DERM NP/PA CME conference. Let’s Start with the Basics What happens before we enter the room? Before entering the room, it’s always best to: Review the patient’s chart for pertinent medical hist …
full body skin exam
Utilizing Melanoma Molecular Tests for Diagnosis and Treatment
melanoma molecular testNext Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Mark Gimbel, surgical oncologist with Banner MD Anderson Cancer Center, on how molecular tools are revolutionizing how melanoma is diagnosed, treated and prognosticated. Watch Dr. Gimbel explain the current tests on the market and …
melanoma molecular test